Statistical analysis showed statistically significantly higher IL-1α concentrations in serum of patients with ovarian cancer stage G3 compared to patients in the reference group (p<0.001) and patients in the study group stage G1 vs. G3 (p<0.001) and G2 vs. G3 (p<0.001). The gene discussed is IL1A; the disease is ovarian carcinoma.